IOX1 impedes host inflammation in imiquimod-triggered psoriasis
Psoriasis is a chronic autoimmune disease with an unknown etiology and highly limited treatment strategies. The drugs currently used in the treatment of psoriasis are rarely recommended for long-term use owing to the serious side effects. Although different targets have been identified for controlli...
Guardado en:
Autores principales: | Joo Eun Shin, Su Jin Lee, Amal Gharbi, In Duk Jung, Yeong Min Park |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1d3b67afd8034f4d986d008e72250ff2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Current knowledge on psoriasis and autoimmune diseases
por: Ayala-Fontánez N, et al.
Publicado: (2016) -
Olive Oil Based Methotrexate Loaded Topical Nanoemulsion Gel for the Treatment of Imiquimod Induced Psoriasis-like Skin Inflammation in an Animal Model
por: Sheikh Abdur Rashid, et al.
Publicado: (2021) -
Psoriasis and Cardiometabolic Diseases: The Impact of Inflammation on Vascular Health
por: Teklu M, et al.
Publicado: (2021) -
Psoriasis
por: MOLL LEE,NORMAN
Publicado: (1947) -
Psoriasis eritrodérmica y psoriasis artropática: Relate de dos casos
por: STEEGER,ADALBERTO, et al.
Publicado: (1956)